5axe: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<StructureSection load='5axe' size='340' side='right'caption='[[5axe]], [[Resolution|resolution]] 0.95Å' scene=''> | <StructureSection load='5axe' size='340' side='right'caption='[[5axe]], [[Resolution|resolution]] 0.95Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5axe]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5AXE OCA]. For a <b>guided tour on the structure components</b> use [ | <table><tr><td colspan='2'>[[5axe]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5AXE OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5AXE FirstGlance]. <br> | ||
</td></tr><tr id=' | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=LSH:[(1R,5R,7R,8S)-7-[5-METHYL-2,4-BIS(OXIDANYLIDENE)PYRIMIDIN-1-YL]-8-OXIDANYL-3,3-BIS(OXIDANYLIDENE)-6-OXA-3$L^{6}-THIA-2-AZABICYCLO[3.2.1]OCTAN-5-YL]METHYL+DIHYDROGEN+PHOSPHATE'>LSH</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5axe FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5axe OCA], [https://pdbe.org/5axe PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5axe RCSB], [https://www.ebi.ac.uk/pdbsum/5axe PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5axe ProSAT]</span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
| Line 22: | Line 21: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Aoyama | [[Category: Synthetic construct]] | ||
[[Category: Fujimura | [[Category: Aoyama H]] | ||
[[Category: Hari | [[Category: Fujimura Y]] | ||
[[Category: Kugimiya | [[Category: Hari Y]] | ||
[[Category: Mitsuoka | [[Category: Kugimiya A]] | ||
[[Category: Noda | [[Category: Mitsuoka Y]] | ||
[[Category: Obika | [[Category: Noda M]] | ||
[[Category: Sawamura | [[Category: Obika S]] | ||
[[Category: Tahara | [[Category: Sawamura M]] | ||
[[Category: Wada | [[Category: Tahara S]] | ||
[[Category: Waki | [[Category: Wada F]] | ||
[[Category: Yamamoto | [[Category: Waki R]] | ||
[[Category: Yamamoto T]] | |||
Revision as of 09:29, 31 May 2023
Crystal Structure Analysis of DNA Duplexes containing sulfoamide-bridged nucleic acid (SuNA-NH)Crystal Structure Analysis of DNA Duplexes containing sulfoamide-bridged nucleic acid (SuNA-NH)
Structural highlights
Publication Abstract from PubMedA sulfonamide-bridged nucleic acid without an N-substituent (SuNA[NH]) was successfully synthesized. A comparison of the SuNA[NMe]- and SuNA[NH]-modified oligonucleotides revealed that the duplex-forming abilities of the SuNA[NMe]-modified oligonucleotides with complementary DNA and RNA were higher than those of the SuNA[NH]-modified oligonucleotides. The crystal structures of DNA duplexes containing a SuNA[NR] revealed that the helical structures of the two duplexes and hydration patterns around the bridge moiety were different. These results provide insights into hydration patterns and rationale for the high RNA affinity of SuNA-modified oligonucleotides. Effect of an N-substituent in sulfonamide-bridged nucleic acid (SuNA) on hybridization ability and duplex structure.,Mitsuoka Y, Aoyama H, Kugimiya A, Fujimura Y, Yamamoto T, Waki R, Wada F, Tahara S, Sawamura M, Noda M, Hari Y, Obika S Org Biomol Chem. 2016 Jul 6;14(27):6531-8. doi: 10.1039/c6ob01051b. PMID:27296230[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
|
| ||||||||||||||||